French device-developer CarThera has secured €9m ($10.3m) to develop SonoCloud, an ultrasound technology designed to make the blood-brain barrier more permeable and increase penetration of drugs into the brain to improve treatments for patients with brain tumors and neurodegenerative diseases.
The $10m is the first financial backing the company has received from institutional investors and marks a key milestone in...







